126 related articles for article (PubMed ID: 10549262)
1. Allelotype of uterine leiomyomas.
Mao X; Barfoot R; Hamoudi RA; Easton DF; Flanagan AM; Stratton MR
Cancer Genet Cytogenet; 1999 Oct; 114(2):89-95. PubMed ID: 10549262
[TBL] [Abstract][Full Text] [Related]
2. Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q.
van der Heijden O; Chiu HC; Park TC; Takahashi H; LiVolsi VA; Risinger JI; Barrett JC; Berchuck A; Evans AC; Behbakht K; Menzin AW; Liu PC; Benjamin I; Morgan MA; King SA; Rubin SC; Boyd J
Mol Carcinog; 1998 Dec; 23(4):243-7. PubMed ID: 9869453
[TBL] [Abstract][Full Text] [Related]
3. Microallelotyping defines novel regions of loss of heterozygosity in uterine leiomyomas.
Canevari Rde A; Pontes A; Rogatto SR
Mol Carcinog; 2005 Mar; 42(3):177-82. PubMed ID: 15605361
[TBL] [Abstract][Full Text] [Related]
4. Association of the shrinkage of uterine leiomyoma treated with GnRH agonist and deletion of long arm of chromosome 7.
Takahashi K; Kawamura N; Tsujimura A; Ichimura T; Ito F; Ishiko O; Ogita S
Int J Oncol; 2001 Jun; 18(6):1259-63. PubMed ID: 11351260
[TBL] [Abstract][Full Text] [Related]
5. Frequent loss of heterozygosity for chromosome 10 in uterine leiomyosarcoma in contrast to leiomyoma.
Quade BJ; Pinto AP; Howard DR; Peters WA; Crum CP
Am J Pathol; 1999 Mar; 154(3):945-50. PubMed ID: 10079273
[TBL] [Abstract][Full Text] [Related]
6. Two discrete regions of deletion at 7q in uterine leiomyomas.
Ishwad CS; Ferrell RE; Hanley K; Davare J; Meloni AM; Sandberg AA; Surti U
Genes Chromosomes Cancer; 1997 Jul; 19(3):156-60. PubMed ID: 9218996
[TBL] [Abstract][Full Text] [Related]
7. Molecular and cytogenetic analysis of chromosome 7 in uterine leiomyomas.
Ishwad CS; Ferrell RE; Davare J; Meloni AM; Sandberg AA; Surti U
Genes Chromosomes Cancer; 1995 Sep; 14(1):51-5. PubMed ID: 8527384
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide analysis of loss of heterozygosity and copy number amplification in uterine leiomyomas using the 100K single nucleotide polymorphism array.
Meadows KL; Andrews DM; Xu Z; Carswell GK; Laughlin SK; Baird DD; Taylor JA
Exp Mol Pathol; 2011 Aug; 91(1):434-9. PubMed ID: 21497600
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of CYP17A1, CYP19, and androgen in Brazilian women with uterine leiomyomas.
Rosa FE; Canevari Rde A; Ambrosio EP; Ramos Cirilo PD; Pontes A; Rainho CA; Rogatto SR
Clin Chem Lab Med; 2008; 46(6):814-23. PubMed ID: 18601603
[TBL] [Abstract][Full Text] [Related]
10. No microsatellite instability using Bethesda panel and revised markers in uterine leiomyomas.
Hong JM; Lee JH; Gwon GJ; Kim DK
APMIS; 2014 Jan; 122(1):1-4. PubMed ID: 24373030
[TBL] [Abstract][Full Text] [Related]
11. Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II.
Mao X; Hamoudi RA; Talbot IC; Baudis M
Cancer Genet Cytogenet; 2006 May; 167(1):1-14. PubMed ID: 16682279
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas.
Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M
Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071
[TBL] [Abstract][Full Text] [Related]
13. Analysis of genetic alterations in uterine leiomyomas and leiomyosarcomas by comparative genomic hybridization.
Packenham JP; du Manoir S; Schrock E; Risinger JI; Dixon D; Denz DN; Evans JA; Berchuck A; Barrett JC; Devereux TR; Ried T
Mol Carcinog; 1997 Aug; 19(4):273-9. PubMed ID: 9290705
[TBL] [Abstract][Full Text] [Related]
14. Clonally related uterine leiomyomas are common and display branched tumor evolution.
Mehine M; Heinonen HR; Sarvilinna N; Pitkänen E; Mäkinen N; Katainen R; Tuupanen S; Bützow R; Sjöberg J; Aaltonen LA
Hum Mol Genet; 2015 Aug; 24(15):4407-16. PubMed ID: 25964426
[TBL] [Abstract][Full Text] [Related]
15. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
16. Chromosome analysis of uterine adenomyosis. Detection of the leiomyoma-associated del(7q) in three cases.
Pandis N; Karaiskos C; Bardi G; Sfikas K; Tserkezoglou A; Fotiou S; Heim S
Cancer Genet Cytogenet; 1995 Apr; 80(2):118-20. PubMed ID: 7736427
[TBL] [Abstract][Full Text] [Related]
17. A uterine leiomyoma showing both t(12;14) and del(7) abnormalities.
Sait SN; Dal Cin P; Ovanessoff S; Sandberg AA
Cancer Genet Cytogenet; 1989 Feb; 37(2):157-61. PubMed ID: 2702616
[TBL] [Abstract][Full Text] [Related]
18. Allelotype analysis of chemically induced squamous cell carcinomas in F(1) hybrids of two inbred mouse strains with different susceptibility to tumor progression.
Stern MC; Benavides F; Klingelberger EA; Conti CJ
Carcinogenesis; 2000 Jul; 21(7):1297-301. PubMed ID: 10874006
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling.
Quade BJ; Wang TY; Sornberger K; Dal Cin P; Mutter GL; Morton CC
Genes Chromosomes Cancer; 2004 Jun; 40(2):97-108. PubMed ID: 15101043
[TBL] [Abstract][Full Text] [Related]
20. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.
Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA
Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
